Company

About

Bexion Pharmaceuticals

Bexion Pharmaceuticals

Covington, Kentucky, United States

Bexion Pharmaceuticals is a mid-stage clinical company developing life-changing treatments in Oncology and CNS. The company’s lead compound, BXQ-350, is a novel S1P modulator. With our highly experienced biotech leadership team and expertise in Oncology, we are urgently progressing our pipeline to develop life-changing oncology therapies on our path to becoming a leading biotech/pharmaceutical company.

BioinfoScientist

BioinfoScientist

Louisville, Kentucky, United States

Demeetra AgBio

Demeetra AgBio

Lexington, Kentucky, United States

Centrally located in the Bluegrass State of Kentucky, Demeetra has built extensive gene editing know-how, complementing our internally developed as well as globally sourced portfolio of intellectual property. Our scientific team is composed of experts with diverse backgrounds in gene editing, ranging from microbes and plants, to mammalian cells. Scientific achievements include being the first to successfully edit plants and yeast with our precise Cas-CLOVER technology. Demeetra's core focus is developing and optimizing gene editing technologies in commercially applicable systems. We transfer this new knowledge to our partners and provide simple commercial licenses with freedom to operate. We have experience in partnering and out-licensing with top pharmaceutical, biotech, and agtech companies. Our team works closely with collaborators to ensure successful implementation of Demeetra's gene editing technologies for their specific application.

Hema Biologics

Hema Biologics

Louisville, Kentucky, United States

HEMA Biologics is a privately held biopharmaceutical company exclusively focused on meeting the needs of patients living with the rarest bleeding disorders. We aspire to support patients living with these disorders, partner with the broader community that cares for them, and bring meaningful treatments and services to help better their daily lives. Our product development focus is on rare bleeding disorders. Our product development focus is for the treatment of hemophilia A or B with inhibitors. For people living with these disorders, every day brings challenges. Our primary goal is to advance the treatment and management of these conditions in the US to positively affect patients’ lives. HEMA Biologics takes pride in the heritage of LFB, the manufacturer of its products. LFB is a global leader in manufacturing safe, ultrapure plasma-based products as well as a pioneer in innovative recombinant technologies. We are excited to bring these products and technologies to North America.

Hera BioLabs

Hera BioLabs

Lexington, Kentucky, United States

Hera BioLabs is an innovative service, product, and licensing provider leveraging decades of gene engineering advancements to create superior preclinical models and exceptional cell lines. Customers benefit from our proprietary platforms and integrated services, including: - SRG RAT® –the first commercially available highly immunodeficient rat model optimal for human xenograft studies. - Onsite rat and mouse studies in our AAALAC-accredited vivarium and laboratories. - piggyBac® Non-viral DNA Delivery Platform – a trusted system for cell line engineering and transgenesis, validated by 750+ peer-reviewed publications. - Cas-CLOVER™ Site-Specific Gene Editing Platform – a proven alternative to CRISPR/Cas9 that virtually eliminates off-target insertions and deletions. - CHO-GS-/- platform for high-titer, high-productivity biologics development and manufacturing. - Custom model and cell line development using our best-in-class gene editing tools. While flexible licensing options allow you to take our technologies in-house, our experienced team, working out of US-based facilities, is ready to deliver robust, high-quality data to accelerate your discovery and development journey. Ready to advance your research? Learn More at https://www.herabiolabs.com/

KBio

KBio

3700 airpark dr, owensboro, kentucky, united states

KBio aims to create a new generation of biologics using its plant-based platform that has demonstrated the ability to create drug candidates at a fraction of the time and cost of conventional platforms. The Company is focused on developing novel product candidates in two core areas: 1) Antibody therapies for areas of high unmet need; and 2) Pandemic preparedness and response using its plant-based production system to create antibodies and vaccines in shorter timeframes than industry norms. Formed in December 2021, KBio is a subsidiary of BAT with operations in the UK and U.S.

Norton Healthcare

Norton Healthcare

Louisville, Kentucky, US

Norton Healthcare is a healthcare provider offering medical services through a network of hospitals.

UofL Health

UofL Health

Louisville, US

UofL Health is a fully integrated regional academic health system with nine hospitals, four medical centers, Brown Cancer Center, Eye Institute, nearly 200 physician practice locations, and more than 1,000 providers in Louisville and the surrounding counties, including southern Indiana. Additional access to UofL Health is provided through a partnership with Carroll County Memorial Hospital. Affiliated with the University of Louisville School of Medicine, UofL Health is committed to providing patients with access to the most advanced care available. This includes clinical trials, collaboration on research and the development of new technologies to both save and improve lives. With more than 14,000 team members – physicians, surgeons, nurses, pharmacists and other highly-skilled health care professionals, UofL Health is focused on one mission: to transform the health of communities we serve through compassionate, innovative, patient-centered care. For more information on UofL Health, go to www.UofLHealth.org.